This HTML5 document contains 102 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n8https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72362562
rdf:type
wikibase:Item
schema:description
im November 1993 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в листопаді 1993 scientific article published on 01 November 1993 article scientifique publié en 1993 artículu científicu espublizáu en payares de 1993 wetenschappelijk artikel գիտական հոդված հրատարակված 1993 թվականի նոյեմբերի 1-ին
p:P577
wds:Q72362562-1118620F-167A-431A-B09E-B26E33466747
wdt:P577
1993-11-01T00:00:00Z
p:P2888
wds:Q72362562-02FD996A-633E-4C45-8C8A-1F02D4D08DBA
wdt:P2888
n8:bf00874430
p:P2860
wds:Q72362562-0A0AAE93-2D6A-4677-A300-15AEA8EF5D2F wds:Q72362562-14E9AD62-524F-4E8D-8E0C-DE6330ABDAE2 wds:Q72362562-1588C5EF-CCC8-47AF-926C-FE2F636DC62F wds:Q72362562-07AEBEEC-A9FB-49FC-ADA2-3A3D16990534 wds:Q72362562-E4CCCCA7-20B4-4F80-9844-0AAE8ADD89E1 wds:Q72362562-55BAC283-9FFC-46E6-8F0D-32D8680CFF32 wds:Q72362562-59074CCD-A7B8-4E15-BCA0-34D035E517B9 wds:Q72362562-648C6A64-41F1-44C6-BF72-C322B3C24139 wds:Q72362562-43A9E115-C01A-40F0-AB5E-AFA35B14A239 wds:Q72362562-4FBD2227-C71C-4567-A975-3FEF36A9E8ED wds:Q72362562-23F3ACE4-D993-4765-9061-D322193BD55C wds:Q72362562-2610B5F7-0B2A-4AB8-A110-594A794AF2EF wds:Q72362562-1D7D8434-C265-4D2A-A2DA-8A603EA480A7 wds:Q72362562-1DBE0798-C975-40AF-9F3C-212F6944BA28 wds:Q72362562-22421AA4-A528-4A5E-A998-09742674D9C7 wds:Q72362562-C1BC4BEF-4FDD-41C6-A624-21E8383FF147 wds:Q72362562-C3305DFA-C522-461B-B0A0-07B781F5D11B wds:Q72362562-D7349A38-0539-4F3E-8636-A8EFD0B98E5E wds:Q72362562-B632B167-09C0-4916-BFE4-8ECBD11A8946 wds:Q72362562-B97BFE47-C256-4C69-84AA-B0888DF669B4 wds:Q72362562-BD392C93-0166-4B9F-B029-647E19CF7753 wds:Q72362562-BD460954-73F5-4577-8FEB-4AB393F18C79 wds:Q72362562-A8546AC3-E742-4574-820B-98DE6997FF04 wds:Q72362562-AE8EDF75-8AEE-4D2D-B0C3-ED0C5E13E191 wds:Q72362562-7E09CC6B-BECC-4A6B-8651-7A00B6A6250E wds:Q72362562-8C563718-7BD6-4D45-BB28-57B51CA4E3C4
wdt:P2860
wd:Q68436925 wd:Q68475387 wd:Q67901144 wd:Q41187525 wd:Q70538938 wd:Q54750913 wd:Q66956978 wd:Q33444698 wd:Q67590955 wd:Q33444628 wd:Q69985315 wd:Q35981956 wd:Q66956984 wd:Q70822550 wd:Q71989792 wd:Q55112675 wd:Q70062576 wd:Q33418202 wd:Q40790953 wd:Q33394514 wd:Q66984701 wd:Q72832999 wd:Q69992677 wd:Q52254630 wd:Q44103204 wd:Q72826808
p:P2093
wds:Q72362562-F379E5BE-8F43-4E88-9033-31E7E023A66C wds:Q72362562-521DB9DA-2A25-4278-8BD8-5706305A022B wds:Q72362562-2F31AA07-51C3-40F4-A882-C24B413A2D8A wds:Q72362562-3291A274-1517-4335-BA10-443A75380E17
wdt:P2093
C Mazurek L Benson S Garl E L Schwartz
rdfs:label
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia Phase I clinical and pharmacokinetic study of menogaril
skos:prefLabel
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia Phase I clinical and pharmacokinetic study of menogaril
schema:name
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia Phase I clinical and pharmacokinetic study of menogaril
p:P50
wds:Q72362562-94B8A4A5-0B21-4698-B416-160BBA8D70F4 wds:Q72362562-C8838581-BA70-4637-9023-EB778015375F
wdt:P50
wd:Q100309276 wd:Q90323603
p:P1476
wds:Q72362562-53318F0C-71FA-4619-ADCB-E2B6AC7174C6
wdt:P1476
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia
p:P304
wds:Q72362562-B01BBBE4-3417-4048-B1DA-038A765AEA43
wdt:P304
313-322
p:P31
wds:Q72362562-574AF324-48C7-4BBB-B8EF-7882181F3DFD
wdt:P31
wd:Q13442814
p:P921
wds:Q72362562-00BECB04-8F74-4C25-A6F5-FB1DBD7D398A
wdt:P921
wd:Q976388
p:P698
wds:Q72362562-896811D8-B95D-48F0-A640-DA2B7FBDF4FB
wdtn:P698
n13:8157473
wdt:P698
8157473
p:P1433
wds:Q72362562-EA8BDFBC-4280-44B2-BB13-4043BAE25FDE
wdt:P1433
wd:Q2312231
p:P433
wds:Q72362562-DCCDA905-7BE0-47D6-9FC3-69439F048116
p:P478
wds:Q72362562-74855E66-C963-488E-9DE6-344BF58CE932
wdt:P433
4
wdt:P478
11
p:P356
wds:Q72362562-1767D7FD-B397-4D24-918F-9CB0A3AE82EA
wdtn:P356
n11:BF00874430
wdt:P356
10.1007/BF00874430